Furthermore, the research seeks to improve drug delivery systems, exemplified by advancements in photothermal therapy [5,6] and the development of dual stimuli-responsive nanoparticles for HER2-positive breast cancer therapy [7]. The gene discussed is ERBB2; the disease is breast carcinoma.